Emergency Room Wait Times
Home > Clinical Trials > Clinical Trial Details
<< Back to Results
Request Additional Trial InformationFull Trial Details: ClinicalTrials.gov
Condition: Lung CancerStudy Type: Interventional Phase: Phase IIIStudy Start Date: 02/13/2015Study Completion Date: TBD
This randomized, open-label study will evaluate the safety and efficacy of Atezolizumab (MPDL3280A) in combination with carboplatin + paclitaxel or carboplatin + nab-paclitaxel compared with treatment with carboplatin + nab-paclitaxel in chemotherapy-naïve patients with Stage IV squamous non-small cell lung cancer (NSCLC).
Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.
Set Your Location
Setting your location helps us to show you nearby providers and locations based on your healthcare needs.